Lanham O'Dell & Company’s Eli Lilly LLY Stock Holding History

Lanham O'Dell & Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$393K	Buy	366 +4	+1%	+$3.83K	0.11%	19
2025 Q3	$276K	Buy	362 +5	+1%	+$3.72K	0.09%	25
2025 Q2	$278K	Hold	357	–	–	0.12%	25
2025 Q1	$295K	Hold	357	–	–	0.17%	19
2024 Q4	$276K	Buy	357 +2	+0.6%	+$1.66K	0.15%	21
2024 Q3	$315K	Hold	355	–	–	0.18%	17
2024 Q2	$321K	Sell	355 -78	-18%	-$62.4K	0.18%	18
2024 Q1	$337K	Sell	433 -793	-65%	-$564K	0.17%	21
2023 Q4	$715K	Buy	+1,226	New	+$716K	0.5%	11
2022 Q4	–	Sell	-1,021	Closed	-$330K	–	23
2022 Q3	$330K	Buy	+1,021	New	+$323K	1.17%	17

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lanham O'Dell & Company's LLY Position: Q4 2025 in Review

Lanham O'Dell & Company increased its Eli Lilly (LLY) stake by 1.1% in Q4 2025, buying an estimated $3.83K and bringing the position to 366 shares worth $393K. The position accounts for 0.11% of the portfolio, ranked #19.

Lanham O'Dell & Company first reported a position in LLY in Q3 2022 and has held it in 10 quarters since. The position peaked at $715K in Q4 2023. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

Lanham O'Dell & Company held 366 shares of Eli Lilly worth $393K as of Q4 2025.
Lanham O'Dell & Company bought 4 Eli Lilly shares in Q4 2025, an estimated $3.83K.
Eli Lilly made up 0.11% of Lanham O'Dell & Company's portfolio in Q4 2025, its #19 holding.
Lanham O'Dell & Company first reported a position in Eli Lilly in Q3 2022 and has held it in 10 quarters since.
Lanham O'Dell & Company's Eli Lilly position peaked at $715K in Q4 2023.
4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Lanham O'Dell & Company's 13F filing for Q4 2025, filed 12 Jan 2026.